Scope
AAOS recommends timely surgery, coordinated multidisciplinary care, thromboprophylaxis and multimodal analgesia for older adults with hip fracture. Operative choice depends on fracture stability and location, with arthroplasty preferred for displaced femoral-neck fractures and fixation selected according to the trochanteric pattern. Some recovery decisions remain limited-evidence options.
Written by House with AI assistance · AI-assisted source check 29 October 2026.
This is House’s summary of the cited guidance. The source check is not an independent clinician review. Open the publication for complete recommendations, exceptions, evidence grades and later amendments.
Organize prompt surgery and perioperative support
- Avoid routine preoperative traction; AAOS gives a strong recommendation against it. Surgery within 24–48 hours of admission may improve outcomes, a moderate recommendation that still requires consideration of comorbidity and clinical circumstances. [1]
- Use venous-thromboembolism prophylaxis. The guideline does not identify one preferred drug or duration; select these according to immobility, comorbidity and bleeding risk. Mechanical prophylaxis may be applied when not contraindicated. [1]
- Either spinal or general anaesthesia is appropriate, supported by a strong recommendation. For patients receiving anticoagulants, use the relevant guidance on neuraxial-block timing rather than assuming either technique is universally suitable. [1]
- Use multimodal pain control incorporating a preoperative nerve block. Regional techniques need trained staff, monitoring and rescue resources; anticoagulation or coagulopathy can contraindicate some approaches. [1]
- Use interdisciplinary hip-fracture care to reduce complications and improve outcomes. Co-management can bring together orthopaedics, geriatrics, nursing, nutrition and rehabilitation, addressing pain, medicines, function and prevention of complications such as delirium, falls and constipation. [1]
Choose arthroplasty or fixation for the specific fracture
- For an unstable displaced femoral-neck fracture, prefer arthroplasty to internal fixation. The strong recommendation reflects better reoperation, pain or functional outcomes; the reviewed evidence does not establish a mortality advantage. [1]
- Unipolar and bipolar hemiarthroplasty can both be beneficial for displaced femoral-neck fractures; the recommendation is moderate. This does not establish universal superiority of one design. [1]
- In appropriately selected patients with an unstable displaced femoral-neck fracture, total hip arthroplasty may offer a small functional advantage over hemiarthroplasty at the cost of more complications. Discuss prior function, goals and instability risk with the patient and family; evidence from higher-functioning groups should not automatically be applied to lower-functioning patients. [1]
- Use cemented femoral stems when performing arthroplasty for femoral-neck fracture. Benefits include lower periprosthetic-fracture risk and better short-term outcomes, balanced against increased operating time and blood loss. [1]
- The evidence does not favour a single surgical approach for hip arthroplasty after femoral-neck fracture. Choose the approach with the treating surgical team rather than presenting one as mandated by this guideline. [1]
- For a stable impacted or nondisplaced femoral-neck fracture, hemiarthroplasty, internal fixation or nonoperative care may be considered. This is a limited-strength option, not evidence that all three are equivalent for every patient. [1]
Match fixation to trochanteric stability
- For stable intertrochanteric fractures, either a sliding hip screw or cephalomedullary device is recommended. For unstable intertrochanteric fractures, use a cephalomedullary device; both statements are strong recommendations. [1]
- Use a cephalomedullary device for subtrochanteric or reverse-obliquity fractures. For pertrochanteric fractures, short or long nails are limited-evidence options; do not infer that nail-length evidence resolves every unstable fracture pattern. [1]
Manage blood loss and support mobilization
- For an asymptomatic postoperative hip-fracture patient, the guideline suggests a transfusion threshold no higher than haemoglobin 8 g/dL. This is not a rule for withholding transfusion in symptomatic anaemia: the supporting trial treated cardiac chest pain, heart failure or unexplained tachycardia/hypotension unresponsive to fluids as relevant symptoms. [1]
- In hip-fracture patients, give tranexamic acid to reduce blood loss and transfusion requirements. Exercise caution with strong thrombotic risk factors because many studies excluded previous thrombotic events; this recommendation does not establish one optimal dose or administration route. [1]
- After hip-fracture surgery, immediate full weight bearing as tolerated may be considered. This is a limited-strength option based on low-quality evidence; individual fixation, bone quality, pain and functional limitations matter when determining the postoperative plan. [1]
Limitations and use
- The guideline targets older adults, particularly those aged 65 and over; the evidence selection included populations starting at age 55 with an average age of at least 65. Recommendations should not be generalized to young adults or children with hip fracture.
- This document does not provide a complete thromboprophylaxis regimen, tranexamic-acid dose, neuraxial anticoagulant timing schedule or rehabilitation prescription. Primary and secondary fracture prevention and post-hospital rehabilitation are outside its stated scope.
- The asymptomatic postoperative transfusion recommendation is distinct from decisions in active bleeding, symptomatic anaemia or other clinical settings.
This summary is selective and does not reproduce every recommendation. Apply the source’s population, setting and eligibility criteria, together with clinical judgement and local policy.
Summary sources
- Management of Hip Fractures in Older Adults
Guideline recommendation text consulted
Publication details
- Issuing organisation
- AAOS
- Resource type
- Clinical practice guideline · House clinical summary
- Source setting
- United States
The source check confirms publication details and the linked edition. It does not certify every recommendation or its suitability for an individual patient. Publisher access conditions may apply.